Latest & greatest articles for pneumonia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pneumonia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pneumonia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pneumonia

601. Macrolides in community-acquired pneumonia and otitis media - summary

Macrolides in community-acquired pneumonia and otitis media - summary Macrolides in community-acquired pneumonia and otitis media Macrolides in community-acquired pneumonia and otitis media Perras C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Perras C. Macrolides in community-acquired pneumonia and otitis media. Ottawa: Canadian (...) /therapeutic use; Otitis Media; Pneumonia Language Published English, French Country of organisation Canada Address for correspondence 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392; Email: jills@ccohta.ca AccessionNumber 31998008137 Date bibliographic record published 28/02/1998 Date abstract record published 28/02/1998 Health Technology Assessment (HTA) database Copyright © 2019 Canadian Coordinating Office for Health Technology Assessment Homepage Options

1997 Health Technology Assessment (HTA) Database.

602. Systematic review. The relation between nutrition and nosocomial pneumonia: randomized trials in critically ill patients Full Text available with Trip Pro

Systematic review. The relation between nutrition and nosocomial pneumonia: randomized trials in critically ill patients Systematic review. The relation between nutrition and nosocomial pneumonia: randomized trials in critically ill patients Systematic review. The relation between nutrition and nosocomial pneumonia: randomized trials in critically ill patients Cook D, De Jonghe B, Heyland D Authors' objectives To review the effect of enteral nutrition (EN) on nosocomial pneumonia in critically (...) ill patients, as summarised in randomised clinical trials. Searching Two databases, MEDLINE and EMBASE, were searched from 1980 onwards. The textwords and keywords used to search MEDLINE were: 'critical care', 'intensive care units', 'pneumonia', 'respiratory tract infection', 'mechanical ventilation', 'gastropulmonary', 'enteral nutrition', 'randomized controlled trials' and 'prospective studies'. The terms used to search EMBASE were 'pneumonia', 'prevention' and 'control'. Frequently cited

1997 DARE.

603. Does this patient have community-acquired pneumonia: diagnosing pneumonia by history and physical examination

Does this patient have community-acquired pneumonia: diagnosing pneumonia by history and physical examination Does this patient have community-acquired pneumonia: diagnosing pneumonia by history and physical examination Does this patient have community-acquired pneumonia: diagnosing pneumonia by history and physical examination Metlay J P, Kapoor W N, Fine M J Authors' objectives To assess the performance of the clinical history and the physical examination in the diagnosis of community (...) -acquired pneumonia (CAP). Searching MEDLINE was searched from 1966 to October 1995 for English language medical literature; the search strategy is available from the authors. The reference lists of retrieved articles were also reviewed. Study selection Study designs of evaluations included in the review Initially, case series with less than 10 observations and review articles without original data were excluded. Of the initial included articles, only primary prospective studies of the accuracy

1997 DARE.

604. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients

Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients Bucher H C, Griffith L, Guyatt G H, Opravil M Authors' objectives To examine the efficacy (...) of prophylactic treatments for Pneumocystis (P.) carinii pneumonia and toxoplasma encephalitis in patients with HIV infections in reducing opportunistic infections and mortality. Searching MEDLINE, AIDSLINE, AIDSTRIALS and AIDSDRUGS were searched, as were the Proceedings of the International and European Conferences on AIDS. Bibliographies of identified trials were screened and experts in the field contacted. Study selection Study designs of evaluations included in the review Randomised placebo-controlled

1997 DARE.

605. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis

Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis Rothrock S G, Harper M B, Green S M, Clark M C (...) , Bachur R, McIlmail D P, Giordano P A, Falk J L Authors' objectives To determine whether oral antibiotics prevent meningitis and serious bacterial infections in children with streptococcus pneumoniae occult bacteraemia. Searching MEDLINE was searched for all English language publications concerning bacteraemia, fever or streptococcus pneumoniae from 1966 to April 1996. Bibliographies of all articles retrieved were also examined. Study selection Study designs of evaluations included in the review

1997 DARE.

606. A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube oc

A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube oc A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence (...) of endotracheal tube occlusion A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion Kirton O C, DeHaven B, Morgan J, Morejon O, Civetta J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary

1997 NHS Economic Evaluation Database.

607. Macrolides in community-acquired pneumonia and otitis media

Macrolides in community-acquired pneumonia and otitis media Macrolides in community-acquired pneumonia and otitis media Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology The use of three macrolides; erythromycin compared toazithromycin or clarithromycin for the treatment of community acquired pneumonia (CAP) and otitis media. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients who had received a macrolide, specifically erythromycin, azithromycin or clarithromycin for the treatment of CAP and otitis media. Setting Primary care. The economic study

1997 NHS Economic Evaluation Database.

608. IV cefuroxime plus oral clarithromycin or IV erythromycin for the treatment of community-acquired pneumonia in hospitalised patients: a pilot study

IV cefuroxime plus oral clarithromycin or IV erythromycin for the treatment of community-acquired pneumonia in hospitalised patients: a pilot study IV cefuroxime plus oral clarithromycin or IV erythromycin for the treatment of community-acquired pneumonia in hospitalised patients: a pilot study IV cefuroxime plus oral clarithromycin or IV erythromycin for the treatment of community-acquired pneumonia in hospitalised patients: a pilot study Gotfried M H, Killian A D, Servi R J, Danziger L H (...) , Rodvold K A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of IV cefuroxime together with either oral clarithromycin (group A) or IV erythromycin (group B) for the treatment of community-acquired pneumonia (CAP). Type

1997 NHS Economic Evaluation Database.

609. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia Gleason P P, Kapoor W N, Stone R A, Lave J R, Obrosky D (...) S, Schulz R, Singer D E, Coley C M, Marrie T J, Fine M J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Using American Thoracic Society (ATS) Guidelines for treating adult outpatients with community-acquired pneumonia (CAP

1997 NHS Economic Evaluation Database.

610. Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia

Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia Zarkin G A, Bala M V, Wood L L, Bennett C L, Simpson K (...) , Dohn M N Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Atovaquone, administered on an outpatient basis for treating mild to moderate Pneumocystis carinii pneumonia (PCP). Type of intervention Treatment. Economic study type Cost

1996 NHS Economic Evaluation Database.

611. A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: the optimal duration of therapy

A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: the optimal duration of therapy A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: the optimal duration of therapy A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: the optimal duration of therapy Siegel R E, Halpern N A, Almenoff P L, Lee A, Cashin R, Greene J G Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Shortened course of inpatient IV antibiotic therapy prior to switching to oral antibiotic in the patient with community-acquired pneumonia (CAP). Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population

1996 NHS Economic Evaluation Database.

612. Sputum gram's stain in community-acquired pneumococcal pneumonia: a meta-analysis

Sputum gram's stain in community-acquired pneumococcal pneumonia: a meta-analysis Sputum gram's stain in community-acquired pneumococcal pneumonia: a meta-analysis Sputum gram's stain in community-acquired pneumococcal pneumonia: a meta-analysis Reed W W, Byrd G S, Gates R H, Howard R S, Weaver M J Authors' objectives To evaluate the sensitivity and specificity of the sputum Gram's stain in community-acquired pneumococcal pneumonia (CAPP). In addition, to determine whether a variation in test (...) characteristics was related to factors such as the stain interpreter, the definition of a positive Gram's stain, or control for antibiotic use before testing. Searching MEDLINE was searched from 1966 to 1993 for English language articles, using the keywords 'sputum', 'Gram's stain' and 'pneumonia'. The bibliographies of retrieved articles were also examined. Study selection Study designs of evaluations included in the review No inclusion criteria relating to the study design were specified. Prospective

1996 DARE.

613. Use of tube feeding to prevent aspiration pneumonia

Use of tube feeding to prevent aspiration pneumonia Use of tube feeding to prevent aspiration pneumonia Use of tube feeding to prevent aspiration pneumonia Finucane T E, Bynum J P Authors' objectives To assess the incidence of aspiration pneumonia and mortality in patients with neurogenic dysphagia receiving tube feeding. Searching MEDLINE was searched from 1991 to 1995 using the keywords 'enteral nutrition', 'deglutition disorders' and 'aspiration pneumonia'. Further references were obtained (...) patients were also included. Outcomes assessed in the review The outcomes assessed were aspiration pneumonia and mortality. How were decisions on the relevance of primary studies made? The authors do not state how the papers were selected for the review, or how many of the authors performed the selection. Articles were included if they were published in the English language, included patients with neurogenic causes of dysphagia, and reported aspiration pneumonia or mortality as outcomes in enterally

1996 DARE.

614. Treatment of moderate-to-severe pneumonia in elderly, long-term care facility residents

Treatment of moderate-to-severe pneumonia in elderly, long-term care facility residents Treatment of moderate-to-severe pneumonia in elderly, long-term care facility residents Treatment of moderate-to-severe pneumonia in elderly, long-term care facility residents Nicolle L E, Kirshen A, Boustcha E, Montgomery P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Broad-spectrum antimicrobials (Ceftriaxone) in the treatment of moderate-to-severe pneumonia in elderly residents of long-term care facilities. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Elderly long-term care facility patients with radiologically documented, moderate to severe pneumonia and requiring parenteral therapy

1996 NHS Economic Evaluation Database.

615. Diagnosis and treatment of ventilator-associated pneumonia--Impact on survival. A decision analysis.

Diagnosis and treatment of ventilator-associated pneumonia--Impact on survival. A decision analysis. PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

1996 PedsCCM Evidence-Based Journal Club

616. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure

Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure Wachter R M, Luce J M, Safrin, S, Berrios D C, Charlebois E, Scitovsky A A Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Intensive care for patients with AIDS-related Pneumocystis carinii pneumonia and severe respiratory failure. Type of intervention Treatment Economic study type Cost-effectiveness analysis Study population Patients with AIDS, microbiologically

1995 NHS Economic Evaluation Database.

617. Weekly ventilator circuit changes: a strategy to reduce costs without affecting pneumonia rates

Weekly ventilator circuit changes: a strategy to reduce costs without affecting pneumonia rates Weekly ventilator circuit changes: a strategy to reduce costs without affecting pneumonia rates Weekly ventilator circuit changes: a strategy to reduce costs without affecting pneumonia rates Hess D, Burns E, Romagnoli D, Kacmarek R M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) . A power calculation was conducted to determine the sample size. Study design Non-randomised trial with historical control. Single centre study. Duration of follow-up was 18 months. There was no loss to follow-up. The assessors of patients outcomes were blind to the study. Analysis of effectiveness The analysis of the clinical study was based on intention to treat. The primary health outcomes used in the analysis were ventilator-associated pneumonia rates. Comparability between groups was not addressed

1995 NHS Economic Evaluation Database.

618. The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia

The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia Gallant J E, McAvinue S M, Moore R D, Bartlett J G, Stanton D L, Chaisson R E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Chemoprophylaxis for pneumocystis carinii pneumonia in HIV infected patients. Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis. Study population HIV-infected patients with PCP on sputum or bronchoalveolar lavage smears. Setting One acute hospital in the USA. The economic

1995 NHS Economic Evaluation Database.

619. Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects

Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects Chouaid C, Housset B, Lebeau B Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected patients. Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population HIV-infected patients with suspected PCP. Additional patient characteristics were not specified. Setting Hospital. The study was conducted in Paris, France. Dates

1995 NHS Economic Evaluation Database.

620. Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients: a clinical and cost-analysis study

Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients: a clinical and cost-analysis study Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients: a clinical and cost-analysis study Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia (...) for the diagnosis ofPneumocystis carinii Pneumonia (PCP) in HIV-infected patients. Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population HIV infected patients (88% men and 12% women) with suspected (but no history of) PCP and no PCP-specific prophylaxis or treatment given for more than 48 hours. These individuals had a mean age of 33 years (range 18-55),78% were homosexual, 14% were intravenous drug users, 8% were infected by HIV through blood transfusion

1995 NHS Economic Evaluation Database.